{
  "success": true,
  "sourceFile": "input\\Alexion_NCT04573309_Wilsons_SAP.pdf",
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33
  ],
  "modelUsed": "claude-opus-4-5",
  "sapData": {
    "analysisPopulations": [
      {
        "id": "pop_1",
        "name": "Screened Set",
        "populationType": "Other",
        "instanceType": "AnalysisPopulation",
        "label": "Screened Set",
        "description": "All participants who signed informed consent and were screened for the study",
        "criteria": "Signed informed consent and screened"
      },
      {
        "id": "pop_2",
        "name": "Enrolled Set",
        "populationType": "Other",
        "instanceType": "AnalysisPopulation",
        "label": "Enrolled Set",
        "description": "All participants who were enrolled in the study",
        "criteria": "Enrolled in the study"
      },
      {
        "id": "pop_3",
        "name": "Full Analysis Set",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "FAS",
        "description": "All enrolled participants who received at least one dose of ALXN1840",
        "criteria": "Enrolled and received at least one dose of ALXN1840"
      },
      {
        "id": "pop_4",
        "name": "Per Protocol Set",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "PP",
        "description": "All participants in the Full Analysis Set who completed the study without major protocol deviations",
        "criteria": "Full Analysis Set participants who completed the study without major protocol deviations"
      },
      {
        "id": "pop_5",
        "name": "Safety Set",
        "populationType": "Safety",
        "instanceType": "AnalysisPopulation",
        "label": "Safety Set",
        "description": "All enrolled participants who received at least one dose of ALXN1840",
        "criteria": "Enrolled and received at least one dose of ALXN1840"
      },
      {
        "id": "pop_6",
        "name": "Pharmacokinetic Analysis Set",
        "populationType": "Pharmacokinetic",
        "instanceType": "AnalysisPopulation",
        "label": "PK Analysis Set",
        "description": "All participants in the Full Analysis Set who have at least one evaluable pharmacokinetic sample",
        "criteria": "Full Analysis Set participants with at least one evaluable PK sample"
      },
      {
        "id": "pop_7",
        "name": "Pharmacodynamic Analysis Set",
        "populationType": "Pharmacodynamic",
        "instanceType": "AnalysisPopulation",
        "label": "PD Analysis Set",
        "description": "All participants in the Full Analysis Set who have at least one evaluable pharmacodynamic sample",
        "criteria": "Full Analysis Set participants with at least one evaluable PD sample"
      }
    ],
    "characteristics": [
      {
        "id": "char_1",
        "name": "Age",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Age at baseline in years"
      },
      {
        "id": "char_2",
        "name": "Sex",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Sex of participant"
      },
      {
        "id": "char_3",
        "name": "Race",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Race of participant"
      },
      {
        "id": "char_4",
        "name": "Ethnicity",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Ethnicity of participant"
      },
      {
        "id": "char_5",
        "name": "Body Mass Index",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Body mass index at baseline"
      },
      {
        "id": "char_6",
        "name": "Baseline Disease Characteristics",
        "dataType": "Mixed",
        "instanceType": "Characteristic",
        "description": "Wilson Disease characteristics at baseline"
      },
      {
        "id": "char_7",
        "name": "Medical/Surgical History",
        "dataType": "Mixed",
        "instanceType": "Characteristic",
        "description": "Medical and surgical history including WD history"
      },
      {
        "id": "char_8",
        "name": "Prior Medications",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Prior medications including those used to treat Wilson Disease"
      },
      {
        "id": "char_9",
        "name": "Concomitant Medications/Therapies",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Concomitant medications and therapies during the study"
      },
      {
        "id": "char_10",
        "name": "Treatment Experience Status",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Classification as treatment-experienced (WD therapy >28 days) or treatment-naïve (WD therapy ≤28 days)"
      }
    ],
    "summary": {
      "populationCount": 7,
      "characteristicCount": 10
    }
  }
}